• NEW YORK, NY How do I update this listing?
Also known as:
Knoll Capital Management is based out of New York. Their last reported 13F filing for Q2 2019 included $122,151,000 in managed 13F securities and a top 10 holdings concentration of 89.53%. Knoll Capital Management's largest holding is Corbus Pharmaceuticals Holdings Inc with shares held of 4,985,870. Knoll Capital Management has met the qualifications for inclusion in our WhaleScore system. Whalewisdom has at least 47 13F filings, 2 13D filings, 44 13G filings, and 1 Form 4 filings